Andes Virus Explained: Why This Hantavirus Is Different

Q: Could Andes virus become pandemic the way COVID did?

Public health experts consider this very unlikely. Andes virus requires close, sustained contact for transmission, has a long incubation period that allows public health teams to track contacts, and produces severe symptoms early enough that asymptomatic spread is uncommon.

Medically reviewed by Shane D. Naidoo, MD
Medical Director, TrufaMED Urgent Care & Concierge Medicine
Board-Certified, Emergency Medicine
Last reviewed: May 10, 2026

The May 2026 cruise ship hantavirus cluster has put a virus most physicians rarely see into the news cycle. The strain involved is called Andes virus, and it is meaningfully different from the hantaviruses Americans usually hear about. This article explains the difference, and why that difference matters for how patients should think about exposure, symptoms, and risk.

I work emergency medicine in Miami. The single question I have heard most this week from patients is some version of: “Is this the same as the hantavirus my friend in Arizona told me about?” The honest answer is: similar family, very different behavior.

The hantavirus family at a glance

Hantaviruses are a group of related viruses carried by rodents. There are dozens of identified strains worldwide, organized roughly by geography and host species. Most cause one of two clinical syndromes when they infect humans:

Hantavirus Pulmonary Syndrome (HPS): primarily in the Americas. Causes fever, muscle aches, then rapid respiratory failure. Roughly 36 percent fatality rate in the United States historically.
Hemorrhagic Fever with Renal Syndrome (HFRS): primarily in Eurasia. Causes fever, kidney damage, and bleeding complications. Fatality varies widely by strain.

Andes virus causes a variant of HPS sometimes called Hantavirus Cardiopulmonary Syndrome (HCPS) because cardiovascular collapse is a more prominent feature than in classic HPS. Same family, slightly different presentation.

What makes Andes virus unique

Of all known hantaviruses, Andes virus has one feature no other strain has confirmed: person-to-person transmission. Every other hantavirus that infects humans does so through contact with infected rodents, their droppings, urine, or saliva. The classic case is someone cleaning out a long-unused cabin or barn in the southwestern United States and inhaling aerosolized particles from rodent droppings.

Andes virus does this too. Its primary host is the long-tailed pygmy rice rat (Oligoryzomys longicaudatus), found in southern Argentina and Chile. But Andes virus has also been documented to spread directly from one symptomatic human to another, particularly in close, prolonged contact settings: household members, healthcare workers without appropriate protective equipment, and now, on a cruise ship.

This person-to-person transmission is why a cruise ship outbreak is plausible at all. Sin Nombre virus, the dominant U.S. hantavirus, would not produce a cluster on a ship in this way. Andes virus can.

Why “person-to-person” still does not mean “easy to catch”

Hearing that a virus spreads from one human to another tends to trigger a COVID-like fear response. That fear, in this case, is not warranted at the population level.

Andes virus transmission requires close, sustained contact with someone who is actively symptomatic. Casual contact (passing someone in a hallway, sharing public transportation, brief social interactions) is extremely unlikely to result in transmission. The documented household transmission cases involved family members caring for severely ill patients over days, often without barrier precautions.

The CDC has explicitly stated the risk to the U.S. public from the current cluster is extremely low. The seven passengers from the MV Hondius who returned to homes in Arizona, California, Georgia, Texas, and Virginia are being monitored and as of mid-May none are symptomatic. No documented household transmission has occurred among their families.

Comparing the strains: Andes virus vs Sin Nombre virus

For patients trying to make sense of conflicting headlines, here is the practical comparison:

Feature	Andes virus	Sin Nombre virus
Geographic origin	Argentina and Chile	Southwestern United States
Primary rodent host	Long-tailed pygmy rice rat	Deer mouse
Person-to-person transmission	Documented (only known hantavirus with this feature)	Not documented
Clinical syndrome	Hantavirus Cardiopulmonary Syndrome	Hantavirus Pulmonary Syndrome
Incubation period	1 to 8 weeks	1 to 8 weeks
Treatment	Supportive care, ICU-level support	Same
U.S. public risk now	Extremely low (per CDC, May 2026)	Stable, ~25 cases/year nationally

What this means for Miami patients

Three practical implications:

If you have not been on a cruise and you do not handle wild rodents, your Andes virus risk is essentially zero regardless of what the news cycle suggests. Continue normal life.

If you have been on a cruise within the last eight weeks and you develop new fever, severe muscle aches, or respiratory symptoms, get evaluated by a physician. Mention the cruise on your intake form. The probability is still low that any individual symptom set is hantavirus, but the cruise context shifts the differential diagnosis enough that it is worth checking. Our companion article covers the symptom timeline and decision tree in detail.

If you live with someone who has recently been on a cruise and they are symptomatic, basic precautions matter: avoid sharing eating utensils, do not handle their bodily fluids without gloves, and seek medical evaluation for the symptomatic person promptly. Once a person is past the symptomatic phase, transmission risk drops to essentially zero.

What we do at TrufaMED for these visits

For symptom evaluation in any patient with a recent cruise history or other exposure concern, our process is:

Full history including travel, exposure, and symptom timeline
Vital signs and physical exam
Rapid testing for the common viral and bacterial causes that mimic early hantavirus (influenza, COVID-19, RSV, strep, respiratory pathogen panel)
Basic blood work if clinically indicated
Hantavirus-specific testing only when meaningful exposure history aligns with a clinical picture suspicious for HPS or HCPS. The test is sent to a public health lab and takes days to return.
Immediate ER referral and direct hospital coordination if HPS is suspected

We do not stock antiviral therapy for hantavirus because there is no specific antiviral treatment available for any hantavirus strain. Care is supportive, and severe cases require ICU-level support that is delivered at a hospital, not at urgent care. Our role is recognition, ruling out the more common causes, and rapid escalation when needed.

Frequently asked questions

Is Andes virus a new virus?

No. Andes virus was first identified in the mid-1990s in southern Argentina. The May 2026 cruise ship cluster is notable not because the virus is new but because it surfaced in an unusual setting and produced a cluster involving cross-border travel.

Why is Andes virus the only hantavirus that spreads person-to-person?

The biological basis is not fully understood. Researchers have identified differences in viral receptor binding and tissue tropism that may explain the difference, but the precise reason Andes virus can transmit between humans while related strains cannot remains an active area of research.

Could Andes virus become pandemic the way COVID did?

Public health experts, including those interviewed by NPR and major outlets, consider this very unlikely. Andes virus requires close, sustained contact for transmission, has a long incubation period that allows public health teams to track contacts, and produces severe symptoms early enough that asymptomatic spread is uncommon. None of these features support efficient pandemic spread.

Is there a vaccine in development?

Several research groups have been working on hantavirus vaccines for decades. None are currently approved in the United States. The current outbreak may accelerate interest and funding, but a clinically usable vaccine is years away even on an aggressive timeline.

If I had Sin Nombre hantavirus exposure years ago, am I immune to Andes virus?

Cross-immunity between hantavirus strains is partial at best and not well characterized clinically. Prior exposure to one strain does not provide reliable protection against another. The question is also rare in practice because symptomatic hantavirus infection is uncommon enough that most people will never have had it.

Should hospitals in Miami change protocols based on this outbreak?

Most major hospital systems already have protocols for suspected viral hemorrhagic fever and respiratory pathogens of public health concern. The current cluster is on the radar. For our part at TrufaMED, our standard infection control protocols are already aligned with what would be needed to safely evaluate a possible hantavirus case before transfer to a hospital. The Joint Commission accreditation we maintain audits exactly this kind of preparedness.

The bottom line

The May 2026 cruise ship Andes virus cluster is a meaningful public health event but not a public emergency for U.S. patients. The virus is real, the deaths are tragic, and the person-to-person transmission feature distinguishes Andes virus from other hantaviruses. None of that changes the practical advice for Miami patients: monitor for the next eight weeks if you have been on a cruise, get evaluated for any unexplained respiratory or febrile illness in that window, and continue normal life otherwise.

If you have questions or need a clinical evaluation, call (305) 537-6396 or walk in to our Surfside clinic at 9445 Harding Avenue. We are open seven days a week with a board-certified physician on every shift.

Sources cited: CDC Hantavirus Situation Summary May 2026, WHO Disease Outbreak News May 2026, CDC HAN Notice 528, NPR coverage May 7, 2026. This article will be updated as additional clinical data becomes available.